# Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)

> **NCT00751894** · PHASE2 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 30 (estimated)

## Conditions studied

- Solid Malignancies

## Interventions

- **DRUG:** Pegfilgrastim (Neulasta, Amgen)

## Key facts

- **NCT ID:** NCT00751894
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751894, "Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00751894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*